Search Results

You are looking at 1 - 3 of 3 items for :

  • "conventional glucocorticoids" x
Clear All
Open access

V Guarnotta, C Di Stefano, A Santoro, A Ciresi, A Coppola and C Giordano

adjustments according to the physician’s judgment during the 48 months of conventional glucocorticoid and dual-release hydrocortisone treatments. Baseline dose 20 mg/day 25 mg/day 30 mg/day 35 mg/day 40 mg/day Dose at 48 months of

Open access

L M Mongioì, R A Condorelli, S La Vignera and A E Calogero

least in part, the limitations related to conventional glucocorticoid treatment: premature mortality ( 3 ), high frequency of hospitalization for intercurrent illnesses, especially infections ( 3 , 12 ), quality of life impairment ( 13 ), poor

Open access

Ferdinand Roelfsema, Diana van Heemst, Ali Iranmanesh, Paul Takahashi, Rebecca Yang and Johannes D Veldhuis

Lovas K Circadian hormone profiles and insulin sensitivity in patients with Addison’s disease: a comparison of continuous subcutaneous hydrocortisone infusion with conventional glucocorticoid replacement therapy . Clinical Endocrinology 2015 83